Related Experiment Videos
Chronic inflammatory demyelinating polyneuropathy in childhood
1Department of Neurology, St. Louis Children's Hospital, Washington University of Medicine, St. Louis, Missouri 63110, USA.
Pediatric Neurology
|April 13, 2001
Summary
Chronic inflammatory demyelinating polyneuropathy (CIDP) in children is a rare condition causing progressive weakness. Diagnosis involves clinical signs, electrophysiology, and spinal fluid analysis for effective management.
Area of Science:
- Neurology
- Pediatrics
- Immunology
Background:
- Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare neurological disorder affecting children.
- It presents with subacute onset of weakness, typically over two months, potentially leading to loss of ambulation.
- Initial symptoms can resemble Guillain-Barré syndrome, with dysesthesias being common.
Purpose of the Study:
- To review the clinical presentation, diagnosis, and prognosis of CIDP in children.
- To discuss treatment options and immunologic features associated with childhood CIDP.
Main Methods:
- Review of existing literature on childhood CIDP.
- Analysis of clinical findings, electrophysiological studies, and cerebrospinal fluid examination.
- Discussion of treatment strategies and immunological aspects.
Main Results:
- CIDP in children is characterized by proximal greater than distal weakness and diminished reflexes.
- Electrophysiology confirms demyelination, and spinal fluid shows albuminocytologic dissociation.
- Males are more frequently affected than females, with antecedent illnesses or vaccinations in about half of cases.
Conclusions:
- Childhood CIDP requires a comprehensive approach for diagnosis and management.
- Understanding the clinical course, diagnostic markers, and treatment options is crucial for improving patient outcomes.
- Further research into immunologic features may offer targeted therapies.